kabutan

ADR120S receives new orders for two Celution centrifuges

Thu May 28, 2026 4:12 pm JST Catalyst

ADR120S, Inc. <3750> announced after the market close on Thursday that its subsidiary, ADR Therapeutics, has secured new orders for two Celution centrifuges.

The Celution centrifuge rapidly processes cell populations containing stem cells derived from adipose tissue. The orders were received from a regenerative medicine clinic scheduled to open shortly. With installation slated for June 20, the expected sales of 40 million yen will be recognized in the first quarter of the fiscal year ending March 2027. The company noted that the transaction has already been factored into its full-year earnings forecast.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles